← All articles

Diabetic Ketoacidosis: Recognising the Emergency

A community pharmacy triage guide to recognising diabetic ketoacidosis, including ketone thresholds, the SGLT2 inhibitor trap, sick day rules, and when to call 999.

Why this matters

Diabetic ketoacidosis (DKA) is a life-threatening medical emergency caused by a severe shortage of insulin. Without insulin, the body breaks down fat for energy, producing acidic by-products called ketones. When ketones accumulate faster than the body can clear them, the blood becomes acidic and the patient can deteriorate rapidly, particularly in children and those using insulin pumps.1

Community pharmacists may be the first healthcare professional consulted when DKA is developing. Knowing the warning signs, asking the right questions, and responding appropriately can significantly affect the outcome.

DKA most commonly affects people with type 1 diabetes, but it can occur in anyone treated with insulin, in newly presenting undiagnosed type 1 diabetes (particularly in children), and in people taking sodium-glucose cotransporter-2 (SGLT2) inhibitors such as empagliflozin, dapagliflozin, canagliflozin, and ertugliflozin.4 Patients on SGLT2 inhibitors can develop DKA with a normal or near-normal blood glucose level. This is known as euglycaemic DKA, and it is frequently missed because the glucose reading does not raise concern. Any person on these medicines presenting with DKA symptoms needs urgent clinical assessment regardless of what the glucose meter shows. In SGLT2 inhibitor patients, blood ketone testing is preferred to urine testing where available, as urine ketone testing may be less reliable in this context.5

DKA can also occur during pregnancy at lower blood glucose levels than would typically trigger concern. Any pregnant person with diabetes presenting with DKA symptoms warrants immediate hospital assessment, even when glucose levels appear only mildly elevated.1,2

Red flags vs More likely benign

FeatureMore likely benignRed flag ⚠
Breath odourNo unusual smell, or mild halitosisSweet, fruity or acetone-like smell, often described as pear drops or nail varnish remover
Breathing patternNormal rate and depth at restDeep, laboured, often rapid breathing (Kussmaul respiration): the body attempting to correct blood acidity. This is a late and serious sign.
ConsciousnessAlert, fully orientated, conversationalDrowsy, confused, difficult to rouse: this indicates severe acidosis and requires 999 immediately
Nausea and vomitingMild nausea, tolerating fluidsPersistent vomiting, unable to keep fluids down: causes dehydration and makes insulin administration difficult
Blood ketones (if tested)Under 0.6 mmol/L: normal. 0.6 to 1.5 mmol/L: low; follow sick day rules if otherwise well.1.6 to 3 mmol/L: urgent assessment needed. Over 3 mmol/L: advise immediate A&E assessment or call 999 regardless of whether DKA symptoms are clearly present.
Urine ketones (if tested)Negative or trace2+ or more should be treated as high ketones. Do not wait for blood ketone confirmation if DKA symptoms are present or the patient is unwell. Advise immediate A&E assessment or call 999.
Abdominal painMild stomach discomfort perhaps related to nauseaSignificant abdominal pain with nausea or vomiting: a classic DKA symptom that warrants urgent assessment
Glucose on SGLT2 inhibitorNormal glucose, no symptomsNormal or only mildly elevated glucose with DKA symptoms: euglycaemic DKA. Do not be reassured by the glucose reading.

Think DKA if Your Patient Says...

These phrases from any person with diabetes should raise immediate suspicion. You do not need a high glucose reading to act. The clinical picture matters more than any single number.

  • "I cannot stop being sick."
  • "I am drinking constantly but cannot quench my thirst."
  • "I am going to the toilet every hour."
  • "I feel completely exhausted."
  • "My glucose will not come down no matter how much insulin I take."
  • "I have lost weight without trying." (Consider new-onset type 1 diabetes, particularly in a child or young adult presenting with thirst, frequent urination, and unusual tiredness.)
  • "My stomach is really hurting." (Abdominal pain is a classic DKA symptom and commonly accompanies nausea and vomiting.)

Any patient with or without a known diabetes diagnosis presenting with thirst, frequent urination, vomiting, and confusion should be assessed for DKA. In children, DKA is sometimes the first presentation of type 1 diabetes.

🛑 KETONES: A Quick Assessment Framework

Use this prompt list when any person with diabetes presents feeling unwell.

K
Ketones checked?

Has the patient tested blood or urine ketones? Blood ketone testing is preferred, especially in people on SGLT2 inhibitors.

E
Eating and drinking?

Can they tolerate fluids? Persistent vomiting causes dehydration and makes insulin administration difficult or unreliable.

T
Thirst and toilet frequency?

Excessive thirst and frequent urination suggest high glucose or possible new-onset type 1 diabetes.

O
On an SGLT2 inhibitor?

Empagliflozin, dapagliflozin, canagliflozin, or ertugliflozin: DKA can occur at normal blood glucose. If DKA is suspected, the SGLT2 inhibitor should be stopped immediately and urgent medical assessment sought.

N
Nausea, vomiting, or abdominal pain?

Persistent vomiting is a red flag. Abdominal pain is also a classic DKA symptom. Both accelerate deterioration.

E
Exhausted or confused?

Any alteration in consciousness or marked confusion requires 999 immediately.

S
Send if red flags present

Call 999: blood ketones over 3 mmol/L, urine ketones 2+, confusion, Kussmaul breathing, collapse. Urgent same-day assessment: ketones 1.6 to 3 mmol/L or any DKA concern on SGLT2 inhibitor.

Common DKA Triggers

Recognising what brings on DKA helps the pharmacist ask the right questions. There is not always an obvious cause, but these are the most common.

  • Missed, reduced, or incorrectly administered insulin doses
  • Insulin pump failure or accidental dislodgement: pump users can develop DKA very rapidly because only rapid-acting insulin is being delivered. Suspected pump failure with ketones or DKA symptoms requires urgent specialist advice or emergency assessment. Do not rely on repeated pump bolus corrections if delivery failure is suspected.
  • Acute illness: chest infection, urinary tract infection, and gastroenteritis are particularly common triggers
  • New-onset type 1 diabetes: thirst, polyuria (frequent urination), unexplained weight loss, and lethargy in a child or young adult may be the first sign
  • SGLT2 inhibitor use: can trigger DKA at normal blood glucose levels, even in type 2 diabetes
  • Surgical procedures, physical injury, or serious acute illness such as a heart attack
  • Excessive alcohol intake or prolonged fasting

If DKA symptoms are present, do not wait for a clear trigger before acting.

What to do in pharmacy

Call 999 if: blood ketones are above 3 mmol/L regardless of whether DKA symptoms appear clearly present; urine ketones are 2+ or more and the person is unwell or symptomatic; the person is drowsy, confused, or unresponsive; deep laboured breathing (Kussmaul respiration) is present; DKA symptoms are present in someone with no known diabetes diagnosis, particularly a child; suspected insulin pump failure with ketones or DKA symptoms; DKA symptoms with an SGLT2 inhibitor plus vomiting, abdominal pain, deep or rapid breathing, fruity breath, marked fatigue, confusion, or dehydration; or DKA symptoms in a pregnant person with diabetes, even if glucose appears only mildly elevated.

Do not advise the person to drive. Ask someone to take them or call 999. Ask them to bring all their medicines. If DKA is suspected in a person taking an SGLT2 inhibitor, advise them to stop taking it immediately and not to restart unless advised by a clinician after DKA has been excluded or treated.4,5
Advise urgent same-day medical assessment through the diabetes care team or by attending the emergency department if: blood ketones are 1.6 to 3 mmol/L at any level of wellbeing; blood glucose is persistently high and not responding to insulin; vomiting is preventing adequate fluid intake; or the person is on an SGLT2 inhibitor with any DKA concern but symptoms are milder and do not meet the 999 threshold above. For milder SGLT2-related concerns, advise the patient to stop the SGLT2 inhibitor immediately and seek same-day assessment. Do not be reassured by a normal glucose reading in anyone taking an SGLT2 inhibitor.4,5

Pregnant patients require immediate hospital assessment because DKA can occur with only modest glucose elevation, and the condition can deteriorate rapidly with consequences for both mother and fetus.1 Do not manage through pharmacy advice or routine GP referral.

Pharmacy cannot manage DKA. The person needs clinical assessment.
If blood ketones are 0.6 to 1.5 mmol/L and the person is well, support them to follow their sick day rules: do not stop insulin even if not eating, because stopping insulin accelerates ketone production;1 maintain fluids according to their sick day plan (sugar-free fluids are appropriate when glucose is high, but carbohydrate-containing fluids may be needed if glucose is low or normal and insulin must continue); test blood glucose and ketones every two hours; and contact their diabetes team for guidance on insulin dose adjustment. Do not advise correction insulin doses unless the patient is following their own agreed sick day plan or has direct specialist advice.

Seek urgent medical help without delay if vomiting starts, symptoms worsen, ketones rise above 1.5 mmol/L, breathing changes, confusion develops, or the patient cannot keep fluids down. Do not return to the pharmacy as a first step if any of these red flags develop: they require medical escalation.

Key takeaways

  • Any person with diabetes who is vomiting persistently, becoming confused, breathing deeply and rapidly at rest, or has fruity-smelling breath needs urgent hospital assessment.
  • Patients on SGLT2 inhibitors can develop DKA with a completely normal blood glucose reading. If DKA is suspected, advise them to stop the SGLT2 inhibitor immediately and seek urgent medical assessment.
  • Blood ketones above 3 mmol/L or urine ketones 2+ in an unwell patient means emergency assessment, not specialist-only contact. Do not downgrade based on absence of obvious symptoms.

📚 References

  1. Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults. 4th ed. JBDS-IP; 2023. https://www.diabetes.org.uk/professionals/position-statements-reports/specialist-care-for-children-and-adults-and-complications/the-management-of-diabetic-ketoacidosis-in-adults
  2. National Institute for Health and Care Excellence. Diabetic ketoacidosis. NICE Clinical Knowledge Summary. London: NICE; 2022. https://cks.nice.org.uk/topics/diabetic-ketoacidosis/
  3. National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management. NG17. London: NICE; 2022. https://www.nice.org.uk/guidance/ng17
  4. Medicines and Healthcare products Regulatory Agency. SGLT2 inhibitors: updated advice on the risk of diabetic ketoacidosis. Drug Safety Update. 18 April 2016. https://www.gov.uk/drug-safety-update/sglt2-inhibitors-updated-advice-on-diabetic-ketoacidosis
  5. Medicines and Healthcare products Regulatory Agency. SGLT2 inhibitors: recommendations to reduce risk of diabetic ketoacidosis during surgery and other procedures. Drug Safety Update. July 2020. https://www.gov.uk/drug-safety-update/sglt2-inhibitors-recommendations-to-reduce-risk-of-diabetic-ketoacidosis-during-surgery-and-other-procedures
  6. Dhatariya KK, Vellanki P. Treatment of diabetic ketoacidosis (DKA) in adults. Diabetes Care. 2017;40(12):e180-e181. https://diabetesjournals.org/care/article/40/12/e180/36917/

Download the checklist

Download the one-page DKA recognition checklist

Continuing professional development

Test your knowledge

Answer 10 questions on this article. Score 70% or more and you will receive a dated, verifiable certificate for 1 hours of CPD, ready for your portfolio.

Disclaimer: For educational use by healthcare professionals only. Does not replace clinical judgement, local pathways, or NICE guidance. Not for public self-diagnosis.